Multiparametric analysis of the specific immune response against SARS-CoV-2

References

• Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3):2000045. doi: 10.2807/1560-7917.ES.2020.25.3.2000045.
   PubMedGoogle Scholar
• Acuti Martellucci C, Flacco ME, Cappadona R, et al. SARS-CoV-2 pandemic: an overview. Adv Biol Regul. 2020;77:100736. doi: 10.1016/j.jbior.2020.100736.
   PubMedGoogle Scholar
• WHO. WHO coronavirus (COVID-19) dashboard, 2023. accessed 2023 Dec 13. https://covid19.who.int. .
   Google Scholar
• V'kovski P, Kratzel A, Steiner S, et al. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19(3):155–170. doi: 10.1038/s41579-020-00468-6.
   PubMed Web of Science ®Google Scholar
• Beyer DK, Forero A. Mechanisms of antiviral immune evasion of SARS-CoV-2. J Mol Biol. 2022;434(6):167265. doi: 10.1016/j.jmb.2021.167265.
   PubMed Web of Science ®Google Scholar
• Blair JE, Gotimukul A, Wang F, et al. Mild to moderate COVID-19 illness in adult outpatients. Medicine (Baltimore). 2021;100(24):e26371. doi: 10.1097/MD.0000000000026371.
   PubMed Web of Science ®Google Scholar
• Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann Intern Med. 2020;173(5):362–367. doi: 10.7326/M20-3012.
   PubMed Web of Science ®Google Scholar
• Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021;184(4):861–880. doi: 10.1016/j.cell.2021.01.007.
   PubMed Web of Science ®Google Scholar
• Sette A, Crotty S. Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines. Immunol Rev. 2022;310(1):27–46. doi: 10.1111/imr.13089.
   PubMed Web of Science ®Google Scholar
• Tarke A, Sidney J, Kidd CK, et al. Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases. Cell Rep Med. 2021;2:100204. doi: 10.1016/j.xcrm.2021.100204.
   PubMedGoogle Scholar
• Farber DL, Yudanin NA, Restifo NP. Human memory T cells: generation, compartmentalization and homeostasis. Nat Rev Immunol. 2014;14(1):24–35. doi: 10.1038/nri3567.
   PubMed Web of Science ®Google Scholar
• Akbar AN, Terry L, Timms A, et al. Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J Immunol. 1988;140(7):2171–2178. doi: 10.4049/jimmunol.140.7.2171.
   PubMed Web of Science ®Google Scholar
• Dan JM, Mateus J, Kato Y, et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021;371(6529):eabf4063. doi: 10.1126/science.abf4063.
   PubMed Web of Science ®Google Scholar
• Hope JL, Bradley LM. Lessons in antiviral immunity. Science. 2021;371(6528):464–465. doi: 10.1126/science.abf6446.
   PubMed Web of Science ®Google Scholar
• Karlsson AC, Humbert M, Buggert M. The known unknowns of T cell immunity to COVID-19. Sci Immunol. 2020;5(53):eabe8063. doi: 10.1126/sciimmunol.abe8063.
   PubMed Web of Science ®Google Scholar
• Tan H-X, Wragg KM, Kelly HG, et al. Cutting edge: SARS-CoV-2 infection induces robust germinal center activity in the human tonsil. J Immunol. 2022;208(10):2267–2271. doi: 10.4049/jimmunol.2101199.
   PubMed Web of Science ®Google Scholar
• Sakharkar M, Rappazzo CG, Wieland-Alter WF, et al. Prolonged evolution of the human B cell response to SARS-CoV-2 infection. Sci Immunol. 2021;6(56):eabg6916. doi: 10.1126/sciimmunol.abg6916.
   PubMed Web of Science ®Google Scholar
• Marcotte H, Piralla A, Zuo F, et al. Immunity to SARS-CoV-2 up to 15 months after infection. iScience. 2022;25(2):103743. doi: 10.1016/j.isci.2022.103743.
   PubMed Web of Science ®Google Scholar
• Thompson MG, Burgess JL, Naleway AL, et al. Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers - eight U.S. locations, December 2020-March 2021. MMWR Morb Mortal Wkly Rep 2021;70:495–500. doi: 10.15585/mmwr.mm7013e3.
   PubMed Web of Science ®Google Scholar
• Brannock MD, Chew RF, Preiss AJ, et al. Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program. Nat Commun. 2023;14(1):2914. doi: 10.1038/s41467-023-38388-7.
   PubMed Web of Science ®Google Scholar
• Pušnik J, Monzon-Posadas WO, Zorn J, et al. SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection. Nat Commun. 2023;14(1):572. doi: 10.1038/s41467-023-36250-4.
   PubMed Web of Science ®Google Scholar
• Bobrovitz N, Ware H, Ma X, et al. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression. Lancet Infect Dis. 2023;23(5):556–567. doi: 10.1016/S1473-3099(22)00801-5.
   PubMed Web of Science ®Google Scholar
• Broberg E, Nicoll A, Amato-Gauci A. Seroprevalence to influenza A(H1N1) 2009 virus—where are we? Clin Vaccine Immunol. 2011;18(8):1205–1212. doi: 10.1128/CVI.05072-11.
   PubMedGoogle Scholar
• Dowd JB, Palermo T, Brite J, et al. Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010. PLoS One. 2013;8(5):e64921. doi: 10.1371/journal.pone.0064921.
   PubMed Web of Science ®Google Scholar
• Lachmann R, Loenenbach A, Waterboer T, et al. Cytomegalovirus (CMV) seroprevalence in the adult population of Germany. PLoS One. 2018;13(7):e0200267. doi: 10.1371/journal.pone.0200267.
   PubMed Web of Science ®Google Scholar
• Lehmann AA, Kirchenbaum GA, Zhang T, et al. Deconvoluting the T cell response to SARS-CoV-2: Specificity versus chance and cognate cross-reactivity. Front Immunol. 2021;12:635942. doi: 10.3389/fimmu.2021.635942.
   PubMed Web of Science ®Google Scholar
• Wolf C, Köppert S, Becza N, et al. Antibody levels poorly reflect on the frequency of memory B cells generated following SARS-CoV-2, seasonal influenza, or EBV infection. Cells. 2022;11(22):3662. doi: 10.3390/cells11223662.
   PubMed Web of Science ®Google Scholar
• Taiyun W, Simko V. R package “corrplot”: visualization of a correlation matrix (Version 0.92), 2021. accessed 2023 Aug 23. https://github.com/taiyun/corrplot.
   Google Scholar
• Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32(18):2847–2849. doi: 10.1093/bioinformatics/btw313.
   PubMed Web of Science ®Google Scholar
• Quadeer AA, Ahmed SF, McKay MR. Landscape of epitopes targeted by T cells in 852 individuals recovered from COVID-19: meta-analysis, immunoprevalence, and web platform. Cell Rep Med. 2021;2:100312. doi: 10.1016/j.xcrm.2021.100312.
   PubMedGoogle Scholar
• Ssali I, Mugaba S, Watelo AK, et al. Spike protein is a key target for stronger and more persistent T-cell responses—a study of mild and asymptomatic SARS-CoV-2 infection. Int J Infect Dis. 2023;136:49–56. doi: 10.1016/j.ijid.2023.09.001.
   PubMed Web of Science ®Google Scholar
• Kundu R, Narean JS, Wang L, et al. Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts. Nat Commun. 2022;13(1):80. doi: 10.1038/s41467-021-27674-x.
   PubMed Web of Science ®Google Scholar
• Tarke A, Zhang Y, Methot N, et al. Targets and cross-reactivity of human T cell recognition of common cold coronaviruses. Cell Rep Med. 2023;4(6):101088. doi: 10.1016/j.xcrm.2023.101088.
   PubMedGoogle Scholar
• Gao F, Mallajosyula V, Arunachalam PS, et al. Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8+ T cell responses post SARS-CoV-2 infection. Immunity. 2023;56(4):864–878.e4. doi: 10.1016/j.immuni.2023.03.005.
   PubMed Web of Science ®Google Scholar
• Sedegah M, Porter C, Goguet E, et al. Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection. PLoS One. 2022;17(10):e0276241. doi: 10.1371/journal.pone.0276241.
   PubMed Web of Science ®Google Scholar
• Guo L, Wang G, Wang Y, et al. SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study. The Lancet Microbe. 2022;3(5):e348–e356. doi: 10.1016/S2666-5247(22)00036-2.
   PubMedGoogle Scholar
• Le Bert N, Tan AT, Kunasegaran K, et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020;584(7821):457–462. doi: 10.1038/s41586-020-2550-z.
   PubMed Web of Science ®Google Scholar
• Shrock E, Fujimura E, Kula T, MGH COVID-19 Collection & Processing Team, et al. Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity. Science. 2020;370(6520):eabd4250. doi: 10.1126/science.abd4250.
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Moldawer LL, Opal SM, et al. Sepsis and septic shock. Nat Rev Dis Primers. 2016;2(1):16045. doi: 10.1038/nrdp.2016.45.
   PubMed Web of Science ®Google Scholar
• Karakike E, Giamarellos-Bourboulis EJ, Kyprianou M, et al. Coronavirus disease 2019 as cause of viral sepsis: a systematic review and meta-analysis. Crit Care Med. 2021;49(12):2042–2057. doi: 10.1097/CCM.0000000000005195.
   PubMed Web of Science ®Google Scholar
• Shappell CN, Klompas M, Chan C, CDC Prevention Epicenters Program, et al. Use of electronic clinical data to track incidence and mortality for SARS-CoV-2–associated sepsis. JAMA Netw Open. 2023;6(9):e2335728. doi: 10.1001/jamanetworkopen.2023.35728.
   PubMed Web of Science ®Google Scholar
• Chang T, Yang J, Deng H, et al. Depletion and dysfunction of dendritic cells: understanding SARS-CoV-2 infection. Front Immunol. 2022;13:843342. doi: 10.3389/fimmu.2022.843342.
   PubMed Web of Science ®Google Scholar
• Al Saihati HA, Hussein HAM, Thabet AA, et al. Memory T cells discrepancies in COVID-19 patients. Microorganisms. 2023;11(11):2737. doi: 10.3390/microorganisms11112737.
   PubMed Web of Science ®Google Scholar
• Humbert M, Olofsson A, Wullimann D, et al. Functional SARS-CoV-2 cross-reactive CD4+ T cells established in early childhood decline with age. Proc Natl Acad Sci U S A. 2023;120(12):e2220320120. doi: 10.1073/pnas.2220320120.
   PubMed Web of Science ®Google Scholar
• Saini SK, Hersby DS, Tamhane T, et al. SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients. Sci Immunol. 2021;6(58):eabf7550. doi: 10.1126/sciimmunol.abf7550.
   PubMed Web of Science ®Google Scholar
• Koerber N, Priller A, Yazici S, et al. Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents. Nat Commun. 2022;13(1):153. doi: 10.1038/s41467-021-27649-y.
   PubMed Web of Science ®Google Scholar
• Petrova VN, Sawatsky B, Han AX, et al. Incomplete genetic reconstitution of B cell pools contributes to prolonged immunosuppression after measles. Sci Immunol. 2019;4(41):eaay6125. doi: 10.1126/sciimmunol.aay6125.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3.
   PubMed Web of Science ®Google Scholar
• Molani S, Hernandez PV, Roper RT, et al. Risk factors for severe COVID-19 differ by age for hospitalized adults. Sci Rep. 2022;12(1):6568. doi: 10.1038/s41598-022-10344-3.
   PubMed Web of Science ®Google Scholar
• Minervina AA, Pogorelyy MV, Kirk AM, et al. SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8+ T cells. Nat Immunol. 2022;23(5):781–790. doi: 10.1038/s41590-022-01184-4.
   PubMed Web of Science ®Google Scholar
• Mise-Omata S, Ikeda M, Takeshita M, et al. Memory B cells and memory T cells induced by SARS-CoV-2 booster vaccination or infection show different dynamics and responsiveness to the omicron variant. J Immunol. 2022;209(11):2104–2113. doi: 10.4049/jimmunol.2200525.
   PubMed Web of Science ®Google Scholar
• Wang Z, Muecksch F, Schaefer-Babajew D, et al. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. Nature. 2021;595(7867):426–431. doi: 10.1038/s41586-021-03696-9.
   PubMed Web of Science ®Google Scholar
• Song G, He W, Callaghan S, et al. Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection. Nat Commun. 2021;12(1):2938. doi: 10.1038/s41467-021-23074-3.
   PubMed Web of Science ®Google Scholar
• Turner JS, Kim W, Kalaidina E, et al. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature. 2021;595(7867):421–425. doi: 10.1038/s41586-021-03647-4.
   PubMed Web of Science ®Google Scholar
• Poon MML, Rybkina K, Kato Y, et al. SARS-CoV-2 infection generates tissue-localized immunological memory in humans. Sci Immunol. 2021;6(65):eabl9105. doi: 10.1126/sciimmunol.abl9105.
   PubMed Web of Science ®Google Scholar
• Naaber P, Tserel L, Kangro K, et al. Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study, the lancet regional. Lancet Reg Health Eur. 2021;10:100208. doi: 10.1016/j.lanepe.2021.100208.
   PubMedGoogle Scholar
• Sahin U, Muik A, Vogler I, et al. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature. 2021;595(7868):572–577. doi: 10.1038/s41586-021-03653-6.
   PubMed Web of Science ®Google Scholar
• Tan CW, Chia WN, Qin X, et al. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction. Nat Biotechnol. 2020;38(9):1073–1078. doi: 10.1038/s41587-020-0631-z.
   PubMed Web of Science ®Google Scholar
• Nelson RW, Chen Y, Venezia OL, MGH COVID-19 Collection & Processing Team, et al. SARS-CoV-2 epitope-specific CD4+ memory T cell responses across COVID-19 disease severity and antibody durability. Sci Immunol. 2022;7(73):eabl9464. doi: 10.1126/sciimmunol.abl9464.
   PubMed Web of Science ®Google Scholar
• Schramm CA, Moon D, Peyton L, et al. Interaction dynamics between innate and adaptive immune cells responding to SARS-CoV-2 vaccination in non-human primates. Nat Commun. 2023;14(1):7961. doi: 10.1038/s41467-023-43420-x.
   PubMed Web of Science ®Google Scholar
• Deng L, Li P, Zhang X, et al. Risk of SARS-CoV-2 reinfection: a systematic review and meta-analysis. Sci Rep. 2022;12(1):20763. doi: 10.1038/s41598-022-24220-7.
   PubMedGoogle Scholar
• Trabucco Aurilio M, Mennini FS, Ferrari C, et al. Main predictors of COVID-19 vaccination uptake among Italian healthcare workers in relation to variable degrees of hesitancy: result from a cross-sectional online survey. Trop Med Infect Dis. 2022;7(12):419. doi: 10.3390/tropicalmed7120419.
   PubMedGoogle Scholar
• Li M, Luo Y, Watson R, et al. Healthcare workers’ (HCWs) attitudes and related factors towards COVID-19 vaccination: a rapid systematic review. Postgrad Med J. 2023;99(1172):520–528. doi: 10.1136/postgradmedj-2021-140195.
   PubMed Web of Science ®Google Scholar
• https://ockovani.opendatalab.cz/statistiky. accessed 2024 April 4.
   Google Scholar